Table 1. Clinical Characteristics of enrolled patients.
| Parameters | All patients (n = 72) |
|---|---|
| Age (yr) | 43 (17–79) |
| Male, n (%) | 65 (90.3%) |
| Alanine aminotransferase (IU/L) | 107 (18–2495) |
| Albumin (g/L) | 29 (19–45) |
| Blood Urea Nitrogen (mmol/L) | 5.1 (1.9–15.5) |
| Sodium (mmol/L) | 136 (122–144) |
| Total bilirubin (mg/dL) | 18.9 (10.1–42.6) |
| Creatinine (mg/dL) | 1.0 (0.7–3.7) |
| International normalized ratio (INR) | 1.9 (1.5–3.4) |
| White Blood Cells (109/L) | 6.7 (1.7–17.5) |
| HBV DNA (Log10 copies/ml) | 4.4 (1.6–9.5) |
| Cirrhosis, n (%) | 44 (61.1%) |
| MELD scoring | 25 (18–42) |
| MELD-Na scoring | 26 (4–48) |
| CTP scoring | 11 (9–13) |
| Cystatin C (mg/L) | 1.52 (0.81–3.91) |
| Ascites, n (%) | 56 (77.8%) |
| Spontaneous bacterial peritonitis, n (%) | 14 (19.4%) |
| Hepatic encephalopathy, n (%) | 12 (16.7%) |
| Acute kidney injury, n (%) | 5 (6.9%) |
| Antiviral Therapy, n (%) | 70 (97.2%) |
All data were present as median (min-max) or number (%).
MELD: The model for end-stage liver disease
MELD-Na: MELD with incorporation of sodium
CTP: Child-Turcotte-Pugh